Korean J Dermatol.  2005 Jun;43(6):856-859.

A Case of Glucagonoma Syndrome Diagnosed as Necrolytic Migratory Erythema

Affiliations
  • 1Department of Dermatology, College of Medicine, Kosin University, Busan, Korea. ksderm98@unitel.co.kr
  • 2Department of Internal Medcine, College of Medicine, Kosin University, Busan, Korea.

Abstract

Necrolytic migratory erythema (NME) is a typical cutaneous manifestation of glucagonoma syndrome. The entire syndrome consists of NME, glucose intolerance, weight loss, anemia, glossitis, diarrhea, and increased glucagon levels. We herein report a patient with glucagonoma syndrome who was diagnosed as having NME. A 48-year-old male presented with a 2-month history of painful erythematous, desquamative, erosive papules and plaques on both lower extremities. Histological examination revealed an intraepidermal cleft, the presence of vacuolated, pale epidermal cells, and necrosis in the upper epidermis. His glucagon level was 2650 pg/ml, with the upper limit of a normal range being 250 pg/ml. The patient was treated with octreotide, and showed an improvement of the skin eruption with normalization of the glucagon level within 4 weeks.

Keyword

Necrolytic migratory erythema; Glucagonoma syndrome

MeSH Terms

Anemia
Diarrhea
Epidermis
Glossitis
Glucagon
Glucagonoma*
Glucose Intolerance
Humans
Lower Extremity
Male
Middle Aged
Necrolytic Migratory Erythema*
Necrosis
Octreotide
Reference Values
Skin
Weight Loss
Glucagon
Octreotide
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr